MOH - Molina Healthcare, Inc.
NEXT EARNINGS:
Apr 22, 2026
EPS Est: $4.01
|
Rev Est: $11.0B
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$154.82
DETAILS
HIGH:
$224.00
LOW:
$109.00
MEDIAN:
$145.00
CONSENSUS:
$154.82
UPSIDE:
4.39%
Market Cap:
7.64B
Volume:
1,510,710
Avg Volume:
1,769,666
52 Week Range:
121.06-359.97
Sector:
Healthcare
Industry:
Medical - Healthcare Plans
Beta:
0.49
Last Dividend:
$N/A
Exchange:
NYSE
Country:
US
Employees:
18,000
IPO Date:
2003-07-02
EPS (TTM):
8.93
P/E Ratio:
18.68
Revenue (TTM):
45.43B
Total Assets:
15.56B
Total Debt:
3.95B
Cash & Equiv:
4.25B
Rev Growth (5Y):
18.5%
EPS Growth (5Y):
-4.8%
FCF Growth (5Y):
8.0%
ROCE:
9.6%
Debt/Equity:
0.97
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-05 | $-2.75 | $0.43 | -739.5% | $11.4B | $11.2B | +1.3% |
| 2025-10-22 | $1.84 | $3.97 | -53.7% | $11.5B | $11.3B | +1.7% |
| 2025-07-23 | $5.48 | $5.62 | -2.5% | $11.4B | $11.0B | +4.3% |
| 2025-04-23 | $6.08 | $5.97 | +1.8% | $11.1B | $10.8B | +2.8% |
| 2025-02-05 | $5.05 | $5.74 | -12.0% | $10.5B | $10.3B | +2.1% |
| 2024-10-23 | $6.01 | $5.81 | +3.4% | $10.3B | $9.9B | +4.3% |
| 2024-07-24 | $5.86 | $5.50 | +6.5% | $9.9B | $9.7B | +1.2% |
| 2024-04-24 | $5.73 | $5.59 | +2.5% | $9.9B | $9.4B | +5.1% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 45.43B | 40.65B | 34.07B | 31.97B | 27.77B | 19.42B | 16.83B | 18.89B | 19.88B | 17.71B | 14.07B | 9.67B |
| Net Income | 472.00M | 1.18B | 1.09B | 792.00M | 659.00M | 673.00M | 737.00M | 707.00M | (512.00M) | 8.00M | 143.00M | 62.22M |
| EPS | 8.93 | 20.52 | 18.71 | 13.70 | 11.40 | 11.41 | 11.85 | 10.61 | -9.14 | 0.93 | 2.75 | 1.33 |
| Total Assets | 15.56B | 15.63B | 14.89B | 12.31B | 12.21B | 9.53B | 6.79B | 7.15B | 8.47B | 7.45B | 6.58B | 4.43B |
| Total Debt | 3.95B | 3.12B | 2.38B | 2.39B | 2.39B | 2.35B | 1.49B | 1.46B | 2.17B | 1.65B | 1.61B | 887.34M |
| Cash & Equivalents | 4.25B | 4.66B | 4.85B | 4.01B | 4.44B | 4.15B | 2.45B | 2.83B | 3.19B | 2.82B | 2.33B | 1.54B |
| Operating Cash Flow | (535.00M) | 644.00M | 1.66B | 773.00M | 2.12B | 1.89B | 427.00M | (314.00M) | 804.00M | 673.00M | 1.12B | 1.06B |
| Free Cash Flow | (636.00M) | 544.00M | 1.58B | 682.00M | 2.04B | 1.82B | 370.00M | (344.00M) | 718.00M | 497.00M | 993.00M | 945.32M |
| FCF per Share | -12.52 | 9.48 | 27.16 | 11.80 | 35.33 | 30.78 | 5.95 | -5.16 | 12.82 | 9.04 | 19.10 | 20.11 |
| Book Value | 4.07B | 4.50B | 4.21B | 2.96B | 2.63B | 2.10B | 1.96B | 1.65B | 1.34B | 1.65B | 1.56B | 1.01B |
| Cash & ST Investments | 4.25B | 8.99B | 9.11B | 7.50B | 7.64B | 6.03B | 4.40B | 4.51B | 5.71B | 4.58B | 4.13B | 2.56B |
| ROC Equity | 0.12 | 0.26 | 0.26 | 0.27 | 0.25 | 0.32 | 0.38 | 0.43 | -0.38 | 0.00 | 0.09 | 0.06 |